The Castrate Resistant Prostate Cancer Market is Estimated To Witness High Growth Owing To Developments in Cancer Therapies

 

Castrate Resistant Prostate Cancer Market

The global Castrate Resistant Prostate Cancer Market is estimated to be valued at US$ 11.12 Bn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Overview:

Castrate resistant prostate cancer (CRPC) occurs after private cancer has spread to other areas of the body even when therapy lowers testosterone levels. Chemotherapy is given to reduce cancer growth and spread in the body blocking tumors from growing and spreading. Other hormonal therapy medicines and chemotherapy are also used.

 

Market key trends:

One of the key trends in the CRPC market is the emergence of high intensity focused ultrasound (HIFU) as a non-invasive focal therapy. In HIFU, high intensity focused ultrasonic beams are used to destroy diseased prostate tissues through heat generation without harming surrounding normal tissues. It provides targeted treatment of prostate tumors with minimal invasiveness compared to radical prostatectomy or radiotherapy. The advancement of HIFU technology is expected to drive the growth of the CRPC market.

Segment Analysis

The global castrate resistant prostate cancer market is segmented based on drug type, distribution channel, and geography. In terms of drug type, the market is segregated into chemotherapy, hormonal therapy, immunotherapy, and targeted therapy. The chemotherapy segment currently dominates the market due to the wide usage and availability of generic chemotherapeutic agents. These drugs are recommended as a first line treatment option.

 

Key Takeaways

The Global Castrate Resistant Prostate Cancer Market Share is expected to witness high growth, exhibiting CAGR of 8.2% over the forecast period, due to increasing incidence of prostate cancer driven by aging population and sedentary lifestyle.

 

Regional analysis

North America currently dominates the global market and is expected to continue its dominance over the forecast period. This is attributed to presence of advanced healthcare facilities, awareness regarding prostate cancers, and availability of reimbursements. Asia Pacific is expected to be the fastest growing market owing to increasing patient population, rising healthcare spending, and emerging healthcare infrastructure.

 

Key players

Key players operating in the castrate resistant prostate cancer market are Sanofi, Johnson & Johnson Services Inc., Pfizer Inc., Astellas Pharma Inc., Bayer AG, Bristol Myers Squibb, Merck Sharp & Dohme, Novartis International AG, Eli Lilly & Company, and AstraZeneca plc. These players are focusing on launch of advanced therapeutics and expanding their geographical presence through collaborations and acquisitions to strengthen their market position.

Read more

https://www.dailyprbulletin.com/castrate-resistant-prostate-cancer-market-size-share-growth-outlook-2023/

Comments

Post a Comment

Popular posts from this blog

Global Veterinary Equipment and Disposables Market: Trends and Outlook

Image
The veterinary equipment and disposables market is experiencing notable growth and transformation. With the increasing number of pet owners considering their animals as family, there is a growing demand for advanced diagnostic tools, surgical instruments, and consumables in veterinary practices. This trend is also supported by the evolving landscape of veterinary medicine, which now integrates sophisticated equipment like digital radiography and ultrasound. In addition to companion animals, the livestock and poultry industry also relies on specialized veterinary equipment to ensure the health and welfare of animals, contributing to market expansion. Moreover, the emphasis on preventive care and early disease detection has led to a surge in the adoption of veterinary equipment and diagnostics for routine check-ups. The incorporation of technology in veterinary practices, including electronic health records and telemedicine, is further enhancing the efficiency and quality of animal healt
Read more

Clamshell Packaging Market to Grow at High Rate Owing to Rising Demand for Sustainable Packaging Options

Image
  Clamshell Packaging Market The global Clamshell Packaging Market is estimated to be valued at US$ 8.61 Bn in 2023 and is expected to exhibit a CAGR of 3.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.   Clamshell packaging refers to a hinged plastic packaging solution used majorly for food and consumer goods. It provides easy opening and closing functionality along with product protection and tamper resistance. The growth in demand for sustainable and eco-friendly clamshell packaging from various end-use industries is propelling the clamshell packaging market growth.   Market Overview: Clamshell packaging is a two-piece shell that snaps or clicks together to securely hold its content. It is widely used for packaging small consumer goods, food items, cosmetics, electronic accessories, and pharmaceutical products due to its excellent sealability and transparency properties. The rising focus on product safety and
Read more

"Advancements in Wilson's Disease Treatment: A Market Analysis"

Image
  Wilson's disease is a rare genetic disorder that affects the body's ability to metabolize copper, leading to its accumulation in various organs, especially the liver and brain. The treatment landscape for Wilson's disease has seen significant advancements in recent years, offering hope to those affected by this condition. One of the mainstays of Wilson's disease treatment market is copper-chelating agents, such as penicillamine and trientine. These medications work by binding to excess copper in the body and facilitating its removal through urine. They can help control copper levels and prevent further damage to the liver and other organs. In cases where copper-chelating agents are not effective or tolerated, liver transplantation becomes a crucial option. Liver transplantation is a life-saving procedure that replaces the damaged liver with a healthy one, effectively curing the disease. However, it's considered a last resort due to the associated risks and li
Read more